Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
No adverse media involving Graphnet Health found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator action involving Graphnet Health found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Shared care record and population health software supplier; no regulatory or clinical safety actions found in the last 24 months.
Nov 2025: Bath and North East Somerset, Swindon and Wiltshire ICB published its intention to directly award Graphnet, the existing provider, a £2.97m (ex VAT) population health management and shared care record contract from Apr 2027 to Mar 2028, extendable to Mar 2029.
No competitors linked yet.